Circulating Extracellular Vesicles in Alcoholic Liver Disease Affect Skeletal Muscle Homeostasis and Differentiation
Journal of Cachexia, Sarcopenia and Muscle · 2025
DOI: 10.1002/jcsm.13675 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, 2025. Verfasst von Laura Barberi und 14 weiteren Autor:innen. Beteiligte Einrichtung: DAHFMO-Unit of Histology and Medical Embryology, Sapienza University of Rome, Laboratory Affiliated to Istituto Pasteur Italia - Fondazione Cenci Bol…. Hauptthemen laut MEDLINE: Extracellular Vesicles, Muscle, Skeletal, Liver Diseases, Alcoholic. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PRIN 2022, Fondazione Roma, AFM-Telethon.
Abstract (Originalsprache)
Background
The mechanisms underlying muscle alteration associated to alcoholic liver disease (ALD) are not fully understood and the physiopathologic mediators of the liver–muscle interplay remains elusive. We investigated the role of circulating extracellular vesicles (EVs) in ALD as potential mediators of muscle atrophy.
Methods
We established a mouse model of sarcopenia associated to ALD, by feeding mice with an alcoholic diet for 8 weeks. We investigated the effects of hepatic and circulating EVs isolated from these mice (EtOH mice; n = 7 females) on muscle cell cultures, comparing them with EVs from mice fed with a standard diet (CD mice; n = 6 females). Additionally, we examined the impact of circulating EVs from patients with alcohol‐related cirrhosis (7 males and 2 females, mean age 55.4 years) on primary human muscle cells, comparing them with EVs from age‐matched healthy subjects (6 males and 3 females). We analysed the miRNA profile of the EVs to identify potential mediators of ALD‐associated sarcopenia.
Results
We demonstrated that circulating EVs were internalized by muscle cells and that EVs from ALD mice and cirrhotic patients caused alteration in the myogenic program. Molecular analysis revealed that serum EVs from ALD mice reduced protein synthesis in C2C12 cells, decreasing levels of p‐AKT/AKT (−54.6%; p < 0.05), p‐mTOR/mTOR (−54.5%; p < 0.05) and p‐GSK3(Ser9)/GSK3 (−30.63%). Similarly, hepatic EVs induced defects in muscle differentiation, with reduced levels of p‐AKT/AKT (−39.1%; p < 0.05), p‐mTOR/mTOR (−30.1%; p < 0.05) and p‐GSK3(Ser9)/GSK3 (−40%). C2C12 cells treated with either serum or hepatic EtOH‐EVs exhibited upregulated expression of muscle‐specific atrophy markers Atrogin‐1 (+61.2% and +189.5%, respectively; p < 0.05) and MuRF1 (+260.4% and +112.5%, respectively; p < 0.05), along with an increased LC3‐II/‐I ratio (+131.5% and +40.2%, respectively; p < 0.05), indicating enhanced autophagy. MiRNA analysis revealed that both circulating and hepatic EVs from ALD mice showed elevated expression of miR‐21, miR‐155, miR‐223 and miR‐122 (+230% and +292%, respectively; p < 0.01) suggesting their potential role in sarcopenia. Human muscle cells exposed to EVs from cirrhotic patients exhibited reduced protein synthesis and upregulated Atrogin‐1 (+113%; p < 0.05) and MuRF1 (+86.3%; p < 0.05), indicating proteasome activation. Circulating EVs of alcoholic patients showed upregulation of the same miRNAs observed in EtOH mice, including the liver‐specific miR‐122 (+260%; p < 0.05) suggesting, also in human liver disease, a hepatic origin of circulating EVs.
Conclusions
Our study highlights the critical role of ALD‐derived circulating EVs in affecting muscle homeostasis and myogenic program, suggesting potential therapeutic targets for mitigating muscle loss in ALD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- DAHFMO-Unit of Histology and Medical Embryology, Sapienza University of Rome, Laboratory Affiliated to Istituto Pasteur Italia - Fondazione Cenci Bolognetti, Rome, Italy.
- Bone Pathophysiology Research Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
- Core Facilities, Microscopy Area, Istituto Superiore di Sanità, Rome, Italy.
- Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
- Department of Orthopaedics and Traumatology, Policlinico Umberto I, Rome, Italy.
- Scuola Superiore di Studi Avanzati Sapienza (SSAS), Sapienza University of Rome, Rome, Italy.
ORCID-Profile: Antonio Musarò
Förderung
- PRIN 2022
- Fondazione Roma
- AFM-Telethon
- Ateneo Sapienza University
- LBI Rehabilitation Research
- National Recovery and Resilience Plan
- Ateneo de Manila University
Zitieren
APA
Barberi, L., Porcu, C., Boccia, C., Cosentino, M., Nicoletti, C., Peruzzi, B., Iosi, F., Forconi, F., Bagnato, G., Dobrowolny, G., Di Cola, S., Lapenna, L., Cera, G., Merli, M., & Musarò, A. (2025). Circulating Extracellular Vesicles in Alcoholic Liver Disease Affect Skeletal Muscle Homeostasis and Differentiation. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.13675
Vancouver
Barberi L, Porcu C, Boccia C, Cosentino M, Nicoletti C, Peruzzi B, et al. Circulating Extracellular Vesicles in Alcoholic Liver Disease Affect Skeletal Muscle Homeostasis and Differentiation. Journal of Cachexia, Sarcopenia and Muscle. 2025. doi:10.1002/jcsm.13675
BibTeX
@article{Barberi2025,
author = {Barberi, Laura and Porcu, Cristiana and Boccia, Caterina and Cosentino, Marianna and Nicoletti, Carmine and Peruzzi, Barbara and Iosi, Francesca and Forconi, Flavia and Bagnato, Giulia and Dobrowolny, Gabriella and Di Cola, Simone and Lapenna, Lucia and Cera, Gianluca and Merli, Manuela and Musarò, Antonio},
title = {Circulating Extracellular Vesicles in Alcoholic Liver Disease Affect Skeletal Muscle Homeostasis and Differentiation},
journal = {Journal of Cachexia, Sarcopenia and Muscle},
year = {2025},
doi = {10.1002/jcsm.13675}
}
EUVIMED